Literature DB >> 33044310

What General and Pain-associated Psychological Distress Phenotypes Exist Among Patients with Hip and Knee Osteoarthritis?

Trevor A Lentz1,2, Steven Z George1,2, Olivia Manickas-Hill3, Morven R Malay4, Jonathan O'Donnell3, Prakash Jayakumar3, William Jiranek2, Richard C Mather1.   

Abstract

BACKGROUND: Psychological distress can negatively influence disability, quality of life, and treatment outcomes for individuals with hip and knee osteoarthritis (OA). Clinical practice guidelines recommend a comprehensive disease management approach to OA that includes the identification, evaluation, and management of psychological distress. However, uncertainty around the best psychological screening and assessment methods, a poor understanding of the heterogeneity of psychological distress in those with OA, and lack of guidance on how to scale treatment have limited the growth of OA care models that effectively address individual psychological needs. QUESTIONS/PURPOSES: (1) Across which general and pain-related psychological distress constructs do individuals seeking conservative care for hip or knee OA report higher scores than the general population of individuals seeking conservative care for musculoskeletal pain conditions? (2) What common psychological phenotypes exist among nonsurgical care-seeking individuals with hip or knee OA?
METHODS: The sample included participants from the Duke Joint Health Program (n = 1239), a comprehensive hip and knee OA care program, and the Optimal Screening for Prediction of Referral and Outcome (OSPRO) cohort studies (n = 871) comprising individuals seeking conservative care for knee, shoulder, low back, or neck pain. At the initial evaluation, patients completed the OSPRO Yellow Flag (OSPRO-YF) Assessment Tool, which assesses 11 general and pain-related psychological distress constructs (depression, anxiety, fear of movement, self-efficacy for managing one's own pain). We used OSPRO-YF scores to compare levels of psychological distress between the cohorts. Cohen's d effect sizes were calculated to determine the magnitude of differences between the groups, with d = 0.20, d = 0.50, and d = 0.80 indicating small, medium, and large effect sizes, respectively. We used a latent class analysis to derive psychological distress phenotypes in people with OA based on the 11 OSPRO-YF psychological distress indicators. Psychological distress phenotypes are characterized by specific mood, belief, and behavioral factors that differentiate subgroups within a population. Phenotyping can help providers develop scalable treatment pathways that are better tailored to the common needs of patients.
RESULTS: Patients with OA demonstrated higher levels of general and pain-related psychological distress across all psychological constructs except for trait anxiety (that is, anxiety level as a personal characteristic rather than as a response to a stressful situation, like surgery) with small-to-moderate effect sizes. Characteristics with the largest effect sizes in the OA and overall OSPRO cohort were (Cohen's d) general anxiety (-0.66, lower in the OA cohort), pain catastrophizing (the tendency to ruminate over, maginfiy, or feel helpless about a pain experience, 0.47), kinesiophobia (pain-related fear of movement, 0.46), pain self-efficacy (confidence in one's own ability to manage his or her pain, -0.46, lower in the OA cohort), and self-efficacy for rehabilitation (confidence in one's own ability to perform their rehabilitation treatments, -0.44, lower in the OA cohort). The latent class analysis yielded four phenotypes (% sample): high distress (52%, 647 of 1239), low distress (26%, 322 of 1239), low self-efficacy and acceptance (low confidence in managing and willingness to accept pain) (15%, 186 of 1239), and negative pain coping (exhibiting poor pain coping skills) (7%, 84 of 1239). The classification error rate was near zero (2%), and the median of posterior probabilities used to assign subgroup membership was 0.99 (interquartile range 0.98 to 1.00), both indicating excellent model performance. The high-distress group had the lowest mean age (61 ± 11 years) and highest levels of pain intensity (6 ± 2) and disability (HOOS JR: 50 ± 15; KOOS JR: 47 ± 15), whereas the low-distress group had the highest mean age (63 ± 10 years) and lowest levels of pain (4 ± 2) and disability (HOOS JR: 63 ± 15; KOOS JR: 60 ± 12). However, none of these differences met or exceeded anchor-based minimal clinically important difference thresholds.
CONCLUSIONS: General and pain-related psychological distress are common among individuals seeking comprehensive care for hip or knee OA. Predominant existing OA care models that focus on biomedical interventions, such as corticosteroid injection or joint replacement that are designed to directly address underlying joint pathology and inflammation, may be inadequate to fully meet the care-related needs of many patients with OA due to their underlying psychological distress. We believe this because biomedical interventions do not often address psychological characteristics, which are known to influence OA-related pain and disability independent of joint pathology. Healthcare providers can develop new comprehensive hip and knee OA treatment pathways tailored to these phenotypes where services such as pain coping skills training, relaxation training, and psychological therapies are delivered to patients who exhibit phenotypes characterized by high distress or negative pain coping. Future studies should evaluate whether tailoring treatment to specific psychological phenotypes yields better clinical outcomes than nontailored treatments, or treatments that have a more biomedical focus. LEVEL OF EVIDENCE: Level III, diagnostic study.

Entities:  

Mesh:

Year:  2020        PMID: 33044310      PMCID: PMC7899410          DOI: 10.1097/CORR.0000000000001520

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.755


  67 in total

1.  Editorial: The Minimum Clinically Important Difference-The Least We Can Do.

Authors:  Seth S Leopold; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2017-01-25       Impact factor: 4.176

Review 2.  Are cognitive and behavioural factors associated with knee pain? A systematic review.

Authors:  Donna M Urquhart; Pyae P Phyomaung; Julia Dubowitz; Sanduni Fernando; Anita E Wluka; Paul Raajmaakers; Yuanyuan Wang; Flavia M Cicuttini
Journal:  Semin Arthritis Rheum       Date:  2014-07-23       Impact factor: 5.532

3.  Pain and disability in patients with osteoarthritis of hip or knee: the relationship with articular, kinesiological, and psychological characteristics.

Authors:  M E van Baar; J Dekker; J A Lemmens; R A Oostendorp; J W Bijlsma
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

4.  Fear and Avoidance of Movement in People with Chronic Pain: Psychometric Properties of the 11-Item Tampa Scale for Kinesiophobia (TSK-11).

Authors:  Eleni G Hapidou; Mary Ann O'Brien; Michael Raymond Pierrynowski; Eugenio de Las Heras; Madri Patel; Tasneem Patla
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

5.  Prediction of healthcare utilization following an episode of physical therapy for musculoskeletal pain.

Authors:  Trevor A Lentz; Jason M Beneciuk; Steven Z George
Journal:  BMC Health Serv Res       Date:  2018-08-20       Impact factor: 2.655

6.  Matching treatment options for risk sub-groups in musculoskeletal pain: a consensus groups study.

Authors:  Joanne Protheroe; Benjamin Saunders; Bernadette Bartlam; Kate M Dunn; Vince Cooper; Paul Campbell; Jonathan C Hill; Stephanie Tooth; Christian D Mallen; Elaine M Hay; Nadine E Foster
Journal:  BMC Musculoskelet Disord       Date:  2019-06-01       Impact factor: 2.362

Review 7.  Advancing Psychologically Informed Practice for Patients With Persistent Musculoskeletal Pain: Promise, Pitfalls, and Solutions.

Authors:  Francis J Keefe; Chris J Main; Steven Z George
Journal:  Phys Ther       Date:  2018-05-01

8.  Experimental pain phenotyping in community-dwelling individuals with knee osteoarthritis.

Authors:  Josue S Cardoso; Joseph L Riley; Toni Glover; Kimberly T Sibille; Emily J Bartley; Burel R Goodin; Hailey W Bulls; Matthew Herbert; Adriana S Addison; Roland Staud; David T Redden; Laurence A Bradley; Roger B Fillingim; Yenisel Cruz-Almeida
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

9.  Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns.

Authors:  M Mofizul Islam; Jose M Valderas; Laurann Yen; Paresh Dawda; Tanisha Jowsey; Ian S McRae
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

10.  Stratified primary care versus non-stratified care for musculoskeletal pain: findings from the STarT MSK feasibility and pilot cluster randomized controlled trial.

Authors:  J C Hill; S Garvin; Y Chen; V Cooper; S Wathall; B Saunders; M Lewis; J Protheroe; A Chudyk; K M Dunn; E Hay; D van der Windt; C Mallen; N E Foster
Journal:  BMC Fam Pract       Date:  2020-02-11       Impact factor: 2.497

View more
  10 in total

1.  CORR Insights: Are There Distinct Statistical Groupings of Mental Health Factors and Pathophysiology Severity Among People with Hip and Knee Osteoarthritis Presenting for Specialty Care?

Authors:  James A Keeney
Journal:  Clin Orthop Relat Res       Date:  2022-02-01       Impact factor: 4.755

2.  Unhelpful Thoughts and Distress Regarding Symptoms Limit Accommodation of Musculoskeletal Pain.

Authors:  Teun Teunis; Aresh Al Salman; Karl Koenig; David Ring; Amirreza Fatehi
Journal:  Clin Orthop Relat Res       Date:  2022-02-01       Impact factor: 4.755

3.  Are There Distinct Statistical Groupings of Mental Health Factors and Pathophysiology Severity Among People with Hip and Knee Osteoarthritis Presenting for Specialty Care?

Authors:  Tom J Crijns; Niels Brinkman; Sina Ramtin; David Ring; Job Doornberg; Paul Jutte; Karl Koenig
Journal:  Clin Orthop Relat Res       Date:  2022-02-01       Impact factor: 4.755

4.  Surgeon Ratings of the Severity of Idiopathic Median Neuropathy at the Carpal Tunnel Are Not Influenced by Magnitude of Incapability.

Authors:  Faiza Sarwar; Teun Teunis; David Ring; Lee M Reichel; Tom Crijns; Amirreza Fatehi
Journal:  Clin Orthop Relat Res       Date:  2021-11-24       Impact factor: 4.755

5.  CORR Insights®: Unhelpful Thoughts and Distress Regarding Symptoms Limit Accommodation of Musculoskeletal Pain.

Authors:  Paul Edward Levin
Journal:  Clin Orthop Relat Res       Date:  2022-02-01       Impact factor: 4.755

6.  Ultrasound Radiomics-Guided Iliac Fascia Block on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Hip Surgery.

Authors:  Jun Zha; Jinping Ni; Shuo Chen; Haijun Feng; Tuanjie Che; Shigang Qiao
Journal:  Comput Math Methods Med       Date:  2022-05-17       Impact factor: 2.809

7.  Demographic and disease characteristics associated with pain intensity, kinesiophobia, balance, and fall self-efficacy among people with osteoarthritis: a cross-sectional study.

Authors:  Ezinne Chika Ekediegwu; Chigbogu Earnest Akpaenyi; Ifeoma Blessing Nwosu; Ogochukwu Kelechi Onyeso
Journal:  BMC Musculoskelet Disord       Date:  2022-06-06       Impact factor: 2.562

8.  CORR Insights®: What General and Pain-associated Psychological Distress Phenotypes Exist Among Patients with Hip and Knee Osteoarthritis?

Authors:  David Ring
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

9.  Experience of the COVID-19 pandemic as lived by patients with hip and knee osteoarthritis: an Italian qualitative study.

Authors:  Simone Battista; Andrea Dell'Isola; Mattia Manoni; Martin Englund; Alvisa Palese; Marco Testa
Journal:  BMJ Open       Date:  2021-10-27       Impact factor: 3.006

10.  Intra-Articular Injection of Adipose-Derived Stem Cells Ameliorates Pain and Cartilage Anabolism/Catabolism in Osteoarthritis: Preclinical and Clinical Evidences.

Authors:  Bo Yan; Shuaijie Lv; Peijian Tong; Li Yan; Zuxiang Chen; Li Zhou; Qiang Yuan; Le Guo; Letian Shan
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.